Heartflow IPO

Develops non-invasive solutions to assess significant coronary artery disease.

NASDAQ: HTFL

Buy

Buy Private Stock

Sign up to invest in private companies like Heartflow before their IPO.

Sell

Sell Private Stock

Sign up to sell private companies like Heartflow before their IPO.

Overview

Heartflow completed their IPO on August 8, 2025. Now that Heartflow is a public company, Nasdaq Private Market does not actively track its performance. The data below is for reference before the company’s IPO.

HeartFlow is a medical technology company that had developed FFRct Analysis, the first non-invasive solution that enables physicians to more accurately evaluate whether a patient has significant coronary artery disease (CAD) based on both anatomy and physiology.

Sector

Healthcare & Life Sciences

Founded

2007

Headquarters

San Francisco, CA

Heartflow Funding

Heartflow Funding History Pre-IPO

Gain insights into Heartflow funding history prior to their IPO, including the funding round, time period, and amount raised.

Financing Round Date Amount Price per share Valuation
Round Date Amount PPS Valuation
Series F Apr 06, 2023 40M
XXXXX
XXXXX
Series F Apr 06, 2023 175M
XXXXX
XXXXX
Series F Apr 06, 2023 175M
XXXXX
XXXXX
Series F Apr 06, 2023 40M
XXXXX
XXXXX
Series E Jun 11, 2019 65M
XXXXX
XXXXX
Series E Jun 11, 2019 65M
XXXXX
XXXXX
Series E Feb 05, 2018 96M
XXXXX
XXXXX
Series E Feb 05, 2018 96M
XXXXX
XXXXX
Series E Nov 20, 2017 144M
XXXXX
XXXXX
Series E Nov 20, 2017 144M
XXXXX
XXXXX
Series D May 20, 2016 64M
XXXXX
XXXXX
Series D May 20, 2016 64M
XXXXX
XXXXX
Series D Jan 30, 2015 36M
XXXXX
XXXXX
Series D Jan 30, 2015 36M
XXXXX
XXXXX
Series C Feb 10, 2014 30M
XXXXX
XXXXX
Series C Feb 10, 2014 30M
XXXXX
XXXXX
Series C Feb 26, 2012 10M
XXXXX
XXXXX
Series C Feb 26, 2012 10M
XXXXX
XXXXX
Series C Dec 21, 2011 65M
XXXXX
XXXXX
Series C Dec 21, 2011 65M
XXXXX
XXXXX
Series B Feb 04, 2011 3M
XXXXX
XXXXX
Series B Feb 04, 2011 3M
XXXXX
XXXXX
Series B Aug 23, 2010 10M
XXXXX
XXXXX
Series B Aug 23, 2010 4M
XXXXX
XXXXX
Series B Aug 23, 2010 4M
XXXXX
XXXXX
Series B Aug 23, 2010 10M
XXXXX
XXXXX
Series A Apr 06, 2010 2M
XXXXX
XXXXX
Series A Apr 06, 2010 2M
XXXXX
XXXXX
Series A Jul 02, 2009 195K
XXXXX
XXXXX
Series A Jul 02, 2009 195K
XXXXX
XXXXX

Access the PPS, Valuation details, and a wealth of other data by signing up. Source: Nasdaq Private Market

Buy

Buy Private Stock

Sign up to invest in private companies like Heartflow before their IPO.

Sell

Sell Private Stock

Sign up to sell private companies like Heartflow before their IPO.

Heartflow Management Team

Heartflow people and management – Prior to IPO

  • Board Member
    Julie Cullivan
  • Board Member
    Jeff Lightcap
  • Board Member
    William C. Weldon
  • Board Member
    Lonnie Smith
  • Board Member
    Casey Tansey
  • CEO, Board Member, President
    John Farquhar
  • CFO
    Vikram Verghese
  • Chief Medical Officer
    Campbell Rogers
  • Chief Product Officer
    Manish Kapoor
  • Co-Founder, Board Member
    John Stevens
  • Co-Founder, CTO, Board Member
    Charles A. Taylor
  • CTO
    Justin Cambra

Heartflow Valuations & Financials

Looking for private company valuations and share price data?

Nasdaq Private Market Data & Intelligence is the private company valuation database covering 4,000+ venture-backed companies with daily pricing, financing history, and secondary market activity. View real-time NPM data on pre-IPO companies including valuations, private company comparable transactions, and historical share price information — the private company due diligence data sources institutional investors rely on.

Similar Companies

Explore companies

like Heartflow

  • Cerebral

    Healthcare & Life Sciences

    Telemedicine mental health startup, providing evidence-based therapeutic techniques and medication management.

  • Insitro-Logo

    insitro

    Healthcare & Life Sciences

    Drug discovery and development company.

  • Eikon Therapeutics Inc-Logo

    Eikon Therapeutics

    Healthcare & Life Sciences

    Uses revolutionary technology to discover novel treatments for life-threatening diseases.

  • Cedar Inc-Logo

    Cedar

    Healthcare & Life Sciences

    The tech platform uses modern intelligence to improve healthcare financial experiences for everyone.

  • Weareresilience-Logo

    Resilience

    Healthcare & Life Sciences

    Operates as technology-focused biomanufacturing company dedicated to broadening access to complex medicines.

  • Virta Health-Logo

    Virta Health

    Healthcare & Life Sciences

    Online specialty medical clinic focused on reversing type 2 diabetes.

  • Human Longevity Inc.-Logo

    Human Longevity

    Healthcare & Life Sciences

    Healthcare technology for genomic sciences.

  • Transcarent-Logo

    Transcarent

    Healthcare & Life Sciences

    Automates procurement, invoicing, and payments to streamline supply chain operations.

  • Moximed

    Healthcare & Life Sciences

    Implantable Shock Absorbers for Knee osteoarthritis.

FAQ

Questions?

We have answers

Buy Heartflow Stock

Heartflow became publicly traded following its IPO on August 8, 2025, its shares now trade on public stock exchanges under the ticker symbol NASDAQ: HTFL. Before the IPO, Heartflow stock was privately held and available only through private market transactions.

If you’re an accredited investor looking to purchase pre-IPO shares in a private company, Nasdaq Private Market can help you get started. Learn more about investing in the private market or sign up for free to explore available opportunities. Learn more about how private company shares trade prior to an IPO on our investors page.

Sell Heartflow Stock

Following its IPO on August 8, 2025, Heartflow shares trade on public stock exchanges, allowing shareholders to sell stock through a traditional brokerage.

If you currently hold shares in a private company, Nasdaq Private Market may be able to help you explore your sell private company stock. Our platform provides a secure and compliant way to sell your shares on terms that work for both you and the company. To understand how employees sell shares before a company goes public, visit the Employee Shareholders page.

 

Heartflow Stock Price

Following the IPO, Heartflow stock prices can now be viewed publicly on major exchanges. Investors and interested parties can find the current stock price by searching Heartflow’s ticker symbol on financial platforms such as Nasdaq.com or through their preferred brokerage platform.

Heartflow Stock Ticker Symbol

Following its IPO on August 8, 2025, Heartflow stock now trades on public markets under the ticker symbol NASDAQ: HTFL. You can view real-time stock information through widely used financial data platforms.

Criteria to Sell Heartflow Stock

Following the Heartflow IPO, public shares can be sold through any brokerage.

Nasdaq Private Market works with employees, ex-employees, and other private company shareholders of pre-IPO companies to sell their shares. The Nasdaq Private Market platform provides a secure and compliant way to sell your shares on terms that work for both you and the company. To learn more about how to sell private company stock, visit the Employee Shareholders page.

Read more about how to sell shares of a private company and eligibility for selling privately held stock:

 

Criteria to Buy or Invest in Heartflow Stock

Following Heartflow’s initial public offering on August 8, 2025, its shares are now listed on a public exchange and available for purchase through a brokerage account. Investors interested in buying Heartflow stock can do so through their preferred broker, just as they would with any other publicly traded security.

Nasdaq Private Market continues to work with investors seeking exposure to private company opportunities prior to IPO. Through structured transactions and curated offerings, investors can participate in private market activity before companies enter the public markets.

Learn more about the Nasdaq Private Market tool kit for investors on the Investor Trading page.

Heartflow Stock Settlement

Since Heartflow is now publicly traded, public-market share transfers and settlement occur automatically through a brokerage or exchange.

Nasdaq Private Market supports transfer and settlement for privately held company equity. In order to buy or sell private company stock, share ownership must transfer before funds are wired. With Nasdaq Private Market, clients leverage our patented Transfer and Settlement technology which streamlines and manages transfer activity from match to settlement.

To learn more about private company stock Transfer and Settlement, check out the Transfer and Settlement page.

Heartflow IPO

Heartflow completed its IPO on August 8, 2025, and is now publicly available through major financial sources.